Ferid Haddad

7PUBLICATIONS
41CO-AUTHORS
Instruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)SynchrotronsMolecular targetsSynchrotrons and accelerators not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 28, 2026
211At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges.

|Mar 12, 2024
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.

B Happl, T Balber, P Heffeter

|Jul 29, 2023
Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma.

Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet

|Jul 02, 2021
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".

Romain Eychenne, Michel Chérel, Férid Haddad

|Apr 30, 2021
A Monte Carlo Determination of Dose and Range Uncertainties for Preclinical Studies with a Proton Beam.

Arthur Bongrand, Charbel Koumeir, Daphnée Villoing

Pageof 2